CTSH and skin cancer: In the multivariate study, Cathepsin H demonstrated independent inhibitory effects on skin cancer (OR = 0.907, 95% CI: 0.830–0.992, P < .05) and melanoma (OR = 0.925, 95% CI: 0.862–0.993, P < .05).